» Articles » PMID: 26807307

Staphylococcal Enterotoxin B (SEB) Induces Memory CD4 T Cell Anergy and Impairs Recall Immunity to Unrelated Antigens

Overview
Date 2016 Jan 26
PMID 26807307
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Naïve and memory T cells can utilize unique regulatory pathways to promote protection but prevent self-reactivity. A bacterial superantigen SEB exploits unique TCR proximal signaling processes in memory CD4 T cells to induce clonal anergy. The aim of this study was to determine if SEB could antagonize memory CD4 T cells and whether there would be consequences on recall immune responses. We evaluated Ab responses to a T-dependent antigen as a measurement of memory T cell helper function.

Method: BALB/c mice were primed with TNP-RGG to elicit memory B cells and also immunized with an ovalbumin peptide to elicit memory helper T cells. Another group of TNP-RGG immunized mice were used as adoptive transfer recipients of exogenous DO11.10 memory T cells. Mice were challenged with TNP-OVA with or without prior administration of SEB. B cells secreting IgM or IgG TNP-specific Ab were enumerated by ELISPOT as indicators of primary versus secondary humoral immunity.

Results: Comparing the SEB and non-SEB-treated groups, the SEB-treated group failed to produce TNP-specific IgG in response to challenge with TNP-OVA, even if they were previously immunized with OVA. All groups produced IgM, indicating that the primary Ab responses and naïve helper T cells were not impacted by SEB. SEB had no negative impact when DO11.10 × Fyn memory T cells were used as donor cells.

Conclusion: The present study indicated that SEB selectively targeted memory CD4 T cells and prevented helper function. Consequently, recall humoral immunity was lost. The data are most consistent with T cell anergy as opposed to indirect suppression as elimination of Fyn kinase restored helper function. These data suggest that bacterial superantigens can impair post-vaccination memory cell responses to unrelated antigens via their ability to target Vb families and antagonize memory cell activation.

Citing Articles

Immune Checkpoint Molecules as Biomarkers of Bone Infection and Clinical Outcome.

Saito M, McDonald K, Grier A, Grier A, Meghwani H, Rangel-Moreno J bioRxiv. 2025; .

PMID: 39803468 PMC: 11722373. DOI: 10.1101/2024.12.30.630837.


Staphylococcal superantigens evoke temporary and reversible T cell anergy, but fail to block the development of a bacterium specific cellular immune response.

Zhang H, Monk I, Braverman J, Jones C, Brooks A, Stinear T Nat Commun. 2024; 15(1):9872.

PMID: 39543088 PMC: 11564628. DOI: 10.1038/s41467-024-54074-8.


The superantigens SpeC and TSST-1 specifically activate TRBV12-3/12-4 memory T cells.

Shepherd F, Davies K, Miners K, Llewellyn-Lacey S, Kollnberger S, Redman J Commun Biol. 2023; 6(1):78.

PMID: 36670205 PMC: 9854414. DOI: 10.1038/s42003-023-04420-1.


Superantigens and SARS-CoV-2.

Hamdy A, Leonardi A Pathogens. 2022; 11(4).

PMID: 35456065 PMC: 9026686. DOI: 10.3390/pathogens11040390.


Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies.

Clegg J, Soldaini E, McLoughlin R, Rittenhouse S, Bagnoli F, Phogat S Front Immunol. 2021; 12:705360.

PMID: 34305945 PMC: 8294057. DOI: 10.3389/fimmu.2021.705360.


References
1.
Watson A, Lee W . Defective T cell receptor-mediated signal transduction in memory CD4 T lymphocytes exposed to superantigen or anti-T cell receptor antibodies. Cell Immunol. 2006; 242(2):80-90. PMC: 1829409. DOI: 10.1016/j.cellimm.2006.09.008. View

2.
Tomai M, Kotb M, Majumdar G, Beachey E . Superantigenicity of streptococcal M protein. J Exp Med. 1990; 172(1):359-62. PMC: 2188171. DOI: 10.1084/jem.172.1.359. View

3.
Watson A, Mittler J, Lee W . Staphylococcal enterotoxin B induces anergy to conventional peptide in memory T cells. Cell Immunol. 2003; 222(2):144-55. DOI: 10.1016/s0008-8749(03)00117-5. View

4.
Rajewsky K, Schirrmacher V, Nase S, Jerne N . The requirement of more than one antigenic determinant for immunogenicity. J Exp Med. 1969; 129(6):1131-43. PMC: 2138664. DOI: 10.1084/jem.129.6.1131. View

5.
Morra M, Barrington R, Abadia-Molina A, Okamoto S, Julien A, Gullo C . Defective B cell responses in the absence of SH2D1A. Proc Natl Acad Sci U S A. 2005; 102(13):4819-23. PMC: 555707. DOI: 10.1073/pnas.0408681102. View